| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135682 Recombinant Bicistronic Flaviviruses and Methods of Use Thereof |
| 06/09/2011 | US20110135677 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135669 Synthetic agonists of tlr9 |
| 06/09/2011 | US20110135662 FUNCTION MODIFYING NAv 1.7 ANTIBODIES |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135654 Prostate cancer related gene styk1 |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135641 Radioprotectants targeting thrombospondin-1 and cd47 |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135620 Prodrug activation in cancer cells using molecular switches |
| 06/09/2011 | US20110135619 Polypeptides of Alicyclobacillus sp. |
| 06/09/2011 | US20110135607 Viral nucleic acid for the treatment of neurodegenerative disorders |
| 06/09/2011 | US20110135598 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 06/09/2011 | US20110135596 Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof |
| 06/09/2011 | US20110135595 Neuregulin based methods and compositions for treating cardiovascular disease |
| 06/09/2011 | US20110135579 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 06/09/2011 | US20110135575 Metalloprotein mri contrast agents and related methods |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | US20110132760 Nucleic Acid Marker Ladder for Estimating Mass |
| 06/09/2011 | DE102009056944A1 RNA-Aptamere, die den löslichen Interleukin-6-Rezeptor spezifisch binden RNA aptamers that bind specifically to the soluble interleukin-6 receptor |
| 06/09/2011 | DE102009051013A1 Klonierung, Expression und Verwendung saurer Phospholipasen Cloning, expression and use of acidic phospholipases |
| 06/09/2011 | CA2782728A1 Compositions and methods for inhibition of vegf |
| 06/09/2011 | CA2782676A1 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
| 06/09/2011 | CA2782484A1 Mybl2 peptides and vaccines containing the same |
| 06/09/2011 | CA2782459A1 Arf6 as a new target for treating alzheimer's disease |
| 06/09/2011 | CA2782320A1 Compositions and methods for increasing serum half-life of fc fusion proteins |
| 06/09/2011 | CA2782290A1 Expression cassettes for embryo-specific expression in plants |
| 06/09/2011 | CA2782271A1 Imp-3 oligopeptides and vaccines including the same |
| 06/09/2011 | CA2781656A1 Human sweet taste receptor-acting sweet taste regulating substance to sweet taste substance |
| 06/09/2011 | CA2781655A1 Sweet taste receptor-expressing construct, cell body expressing the same, and utilization thereof |
| 06/09/2011 | CA2780757A1 Recombinant bacteria for producing glycerol and glycerol-derived products from sucrose |
| 06/09/2011 | CA2749383A1 Novel hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
| 06/08/2011 | EP2330221A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 06/08/2011 | EP2330220A1 Method for quantification or detection of dna |
| 06/08/2011 | EP2330217A1 Gene expression profiling from FFPE samples |
| 06/08/2011 | EP2330216A1 Microarray synthesis and assembly of gene-length polynucleotides |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2330211A2 Process for producing glutamic acid derivatives |
| 06/08/2011 | EP2330210A1 Process for production of optically active amine derivative |
| 06/08/2011 | EP2330209A1 Method for producing chemical and continuous culture system |
| 06/08/2011 | EP2330208A1 Nanoparticles comprising RNA ligands |
| 06/08/2011 | EP2330207A2 Transgenic plant-based methods for plant pests using RNAi |
| 06/08/2011 | EP2330206A1 A gene from Solanum bulbocastanum conferring resistance to Phytophthora infestans |
| 06/08/2011 | EP2330205A1 Plant cells expressing human glucocerebrosidase |
| 06/08/2011 | EP2330204A1 Production of iduronate-2-sulphatase in plant culture |
| 06/08/2011 | EP2330203A2 Rna constructs |
| 06/08/2011 | EP2330202A2 Cyst nematode resistant transgenic plants |
| 06/08/2011 | EP2330201A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 06/08/2011 | EP2330200A2 Gene expression technique |
| 06/08/2011 | EP2330199A2 Surfactant tolerant cellulase and method for modification thereof |
| 06/08/2011 | EP2330198A1 IL-1 related polypeptides |
| 06/08/2011 | EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/08/2011 | EP2330196A2 Method for isolation of soluble polypeptides |
| 06/08/2011 | EP2330195A2 Method for isolation of soluble polypeptides |
| 06/08/2011 | EP2330194A2 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 06/08/2011 | EP2330191A1 Cloning of cytochrome P450 genes from nicotiana |
| 06/08/2011 | EP2330190A1 Process for production of optically active amine derivative |
| 06/08/2011 | EP2330188A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 06/08/2011 | EP2330187A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseases |
| 06/08/2011 | EP2330186A2 Method for synthesizing protein containing high content of specific amino acid through simultaneous expression with trna of the specific amino acid |
| 06/08/2011 | EP2330184A1 Process for producing useful substance |
| 06/08/2011 | EP2330130A1 Human monoclonal antibodies against CD20 |
| 06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
| 06/08/2011 | EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 06/08/2011 | EP2330123A2 HIV resistance genes |
| 06/08/2011 | EP2330121A2 Binding moieties based on Shark IgNAR domains |
| 06/08/2011 | EP2330120A2 Binding moieties based on Shark IgNAR domains |
| 06/08/2011 | EP2330118A1 Gene conferring resistance to Phytophthora infestans (late-blight) in solanaceae |
| 06/08/2011 | EP2330117A1 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 06/08/2011 | EP2330116A1 Replikin peptides and uses thereof |
| 06/08/2011 | EP2330115A1 Replikin peptides and uses thereof |
| 06/08/2011 | EP2330111A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 06/08/2011 | EP2329854A2 Implant coating with nucleic acids |
| 06/08/2011 | EP2329846A1 Genetically engineered co-expression DNA vaccines, construction methods and uses thereof |
| 06/08/2011 | EP2329843A2 Expressing Hepatitis B Virus surface antigen for vaccine preparation |
| 06/08/2011 | EP2329830A2 Antisense inhibition of PTP1B expression |
| 06/08/2011 | EP2329817A1 Retinoic acid receptor antagonists, miR-10a inhibitors and inhibitors of HOXB1 or HOXB3 repressors for treating pancreatic cancer |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2329710A2 Sex-specific insemination of mammals with low number of sperm cells |
| 06/08/2011 | EP2329708A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 06/08/2011 | EP2329257A1 Devices and methods for the purification, isolation, desalting or buffer/solvent exchange of substances |
| 06/08/2011 | EP2329044A1 Prmt1 for target genes of cancer therapy and diagnosis |
| 06/08/2011 | EP2329028A2 Engineering of bolting resistance in sugar beet by means of the transgenic expression of the beet homologue of flowering time control gene ft |
| 06/08/2011 | EP2329027A1 Transgenic plants comprising as transgene a phosphatidate cytidylyltransferase |
| 06/08/2011 | EP2329026A2 Method for the identification of genes involved in neurodegenerative processes |
| 06/08/2011 | EP2329025A1 Periostin-induced pancreatic regeneration |
| 06/08/2011 | EP2329024A1 An endogenous short hairpin rna and the use of the same |
| 06/08/2011 | EP2329023A1 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction |
| 06/08/2011 | EP2329022A2 Method for obtaining oligonucleotide aptamers and uses thereof |
| 06/08/2011 | EP2329021A2 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| 06/08/2011 | EP2329020A1 Cell surface display of polypeptide isoforms by stop codon readthrough |
| 06/08/2011 | EP2329019A1 Isolation of nucleic acid |
| 06/08/2011 | EP2329018A1 Method for the annotation of natural product gene-clusters and for the generation of novel biologically active chemical entities from dna sequences in silico |
| 06/08/2011 | EP2329017A2 Novel method to generate meganucleases with altered characteristics |
| 06/08/2011 | EP2329016A1 Modified beta-glucosidases with improved stability |